Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '25 Apr 1, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	173,966	159,100	-	-	-	-
Enterprise Value	171,163	157,079	-	-	-	-
Last Close Price	1662.90	1512.33	-	-	-	-
PE Ratio	53.31	51.64	-	-	-	-
Forward PE	41.11	43.46	-	-	-	-
PS Ratio	15.97	15.65	-	-	-	-
PB Ratio	10.94	10.42	-	-	-	-
P/TBV Ratio	14.55	10.42	-	-	-	-
P/FCF Ratio	88.50	-	-	-	-
P/OCF Ratio	59.93	-	-	-	-
PEG Ratio	1.64	1.43	-	-	-	-
EV/Sales Ratio	15.71	15.45	-	-	-	-
EV/EBITDA Ratio	37.50	35.81	-	-	-	-
EV/EBIT Ratio	42.41	40.61	-	-	-	-
EV/FCF Ratio	87.37	-	-	-	-
Debt / Equity Ratio	0.00	0.01	0.02	0.06	0.09	0.07
Debt / EBITDA Ratio	0.01	0.02	0.09	0.22	0.27	0.24
Debt / FCF Ratio	-	0.05	0.31	1.19	-	-
Asset Turnover	-	0.63	0.60	0.57	0.58	-
Inventory Turnover	-	1.17	0.94	0.99	0.88	-
Quick Ratio	-	4.55	2.43	2.71	3.92	3.45
Current Ratio	-	6.31	3.79	4.08	5.74	4.68
Return on Equity (ROE)	-	21.88%	20.06%	16.64%	26.55%	-
Return on Assets (ROA)	-	15.04%	13.26%	11.47%	17.80%	-
Return on Capital (ROIC)	17.06%	16.92%	15.07%	12.70%	19.78%	-
Return on Capital Employed (ROCE)	-	24.80%	22.70%	19.80%	28.10%	23.50%
Earnings Yield	1.88%	1.94%	-	-	-	-
FCF Yield	1.13%	-	-	-	-
Dividend Yield	0.53%	0.58%	-	-	-	-
Payout Ratio	0.00%	23.19%	22.31%	40.31%	2.43%	47.63%
Total Shareholder Return	0.51%	0.58%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.